US Patent 11591381 Gene-edited natural killer cells
Patent 11591381 was granted and assigned to CRISPR Therapeutics on February, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 30, 2021
0
Date of Patent
February 28, 2023
0
Patent Applicant
Patent Application Number
17538699
0
Patent Citations
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11591381 Gene-edited natural killer cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.